Umbilical Cord-Derived Mesenchymal Stem Cells (intrathecal)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Umbilical Cord-Derived Mesenchymal Stem Cells (intrathecal), covering 2025-04-17 to 2025-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS [Phase 1]